Suppr超能文献

外科患者的肠球菌菌血症

Enterococcal bacteremia in surgical patients.

作者信息

Barrall D T, Kenney P R, Slotman G J, Burchard K W

出版信息

Arch Surg. 1985 Jan;120(1):57-63. doi: 10.1001/archsurg.1985.01390250049008.

Abstract

In 73 surgical patients enterococcal bacteremia was preceded by antibiotic administration (n = 58), central venous catheters (n = 52), other-organism bacteremia (n = 44), and gastrointestinal tract operations (n = 41). Surgical wounds and urinary tract infections were the most frequent portal of entry. The overall mortality was 42%. The mortality risk was significantly greater in patients with preceding or concomitant gram-positive bacteremia and four or more days of cephalosporin administration prior to enterococcemia. In 21 patients who had been given cephalosporins and who had gram-positive bacteremia, specific antienterococcal therapy resulted in survival in five of nine patients, compared with three of 12 who survived without therapy. Enterococcal bacteremia in surgical patients follows antibiotic administration, central venous catheter use, other-organism bacteremia, and intra-abdominal operations. Preceding or concomitant gram-positive bacteremia defines a subgroup of patients with high mortality who seem to respond to antienterococcal therapy.

摘要

在73例外科患者中,肠球菌菌血症之前有抗生素使用史(n = 58)、中心静脉导管使用史(n = 52)、其他微生物菌血症(n = 44)以及胃肠道手术史(n = 41)。手术伤口和尿路感染是最常见的感染入口。总体死亡率为42%。在肠球菌血症之前或同时存在革兰氏阳性菌血症以及在肠球菌血症发生前使用头孢菌素达4天或更长时间的患者中,死亡风险显著更高。在21例接受过头孢菌素治疗且存在革兰氏阳性菌血症的患者中,特异性抗肠球菌治疗使9例患者中的5例存活,而未接受治疗的12例患者中有3例存活。外科患者的肠球菌菌血症继发于抗生素使用、中心静脉导管使用、其他微生物菌血症以及腹腔内手术。之前或同时存在的革兰氏阳性菌血症定义了一组高死亡率患者,这些患者似乎对抗肠球菌治疗有反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验